ALLO

Allogene Therapeutics (ALLO) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov^[3], including 2 Phase 2^[1], 4 Phase 1^[2].

ALLO has 3 Form 4 insider filings recorded at the SEC in the past 30 days^[4].